IS IT NECESSARY TO CONTINUE ACID-SECRETION INHIBITATON DRUGS IN PATIENTS WITH CONTROLLED GASTROESOPHAGEAL REFLUX DISEASE SYMPTOMS?
Hironori Tanaka 1
Toshihisa Takeuchi 1
Shun Sasaki 1
Yousuke Mori 1
Akitoshi Hakoda 1
Noriaki Sugawara 1
Taro Iwatsubo 1
Kazuhiro Ota 1
Hiroki Nishikawa 1
1 Osaka Medical and Pharmaceutical University, Osaka, Japan
Topic
Oesophagus
Conference
UEG Week 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]